N -Acetylcysteine Alleviates Phenylephrine-Induced Cardiomyocyte Dysfunction via Engaging PI3K/AKT Signaling Pathway
American Journal of Hypertension · 2024
DOI: 10.1093/ajh/hpad100 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hypertension, 2024. Verfasst von Sheng-Ping Chao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongnan Hospital, Wuhan University, WuhanChina. Hauptthemen laut MEDLINE: Phosphatidylinositol 3-Kinase, Acetylcysteine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: yellow crane of excellence program, Zhongnan disciplinary platform.
Abstract (Originalsprache)
BACKGROUND Increased reactive oxygen species (ROS) and oxidative stress response lead to cardiomyocyte hypertrophy and apoptosis, which play crucial roles in the pathogenesis of heart failure. The purpose of current research was to explore the role of antioxidant N-acetylcysteine (NAC) on cardiomyocyte dysfunction and the underlying molecular mechanisms. METHODS AND RESULTS Compared with control group without NAC treatment, NAC dramatically inhibited the cell size of primary cultured neonatal rat cardiomyocytes (NRCMs) tested by immunofluorescence staining and reduced the expression of representative markers associated with hypertrophic, fibrosis and apoptosis subjected to phenylephrine administration examined by reverse transcription-polymerase chain reaction (RT-PCR) and western blot. Moreover, enhanced ROS expression was attenuated, whereas activities of makers related to oxidative stress response examined by individual assay Kits, including total antioxidation capacity (T-AOC), glutathione peroxidase (GSH-Px), and primary antioxidant enzyme Superoxide dismutase (SOD) were induced by NAC treatment in NRCMs previously treated with phenylephrine. Mechanistically, we noticed that the protein expression levels of phosphorylated phosphatidylinositol 3-kinase (PI3K) and AKT were increased by NAC stimulation. More importantly, we identified that the negative regulation of NAC in cardiomyocyte dysfunction was contributed by PI3K/AKT signaling pathway through further utilization of PI3K/AKT inhibitor (LY294002) or agonist (SC79). CONCLUSIONS Collected, NAC could attenuate cardiomyocyte dysfunction subjected to phenylephrine, partially by regulating the ROS-induced PI3K/AKT-dependent signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Zhongnan Hospital, Wuhan University, WuhanChina.
- Institute of Myocardial Injury and Repair, Wuhan University, Wuhan, China.
- Department of Dermatology, Zhongnan Hospital, Wuhan University, Wuhan, China.
Förderung
- yellow crane of excellence program
- Zhongnan disciplinary platform
Zitieren
APA
Chao, S. P., Cheng, W. L., Yi, W., Cai, H. H., Deng, K., Cao, J. L., Zeng, Z., Wang, H., & Wu, X. (2024). N -Acetylcysteine Alleviates Phenylephrine-Induced Cardiomyocyte Dysfunction via Engaging PI3K/AKT Signaling Pathway. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpad100
Vancouver
Chao SP, Cheng WL, Yi W, Cai HH, Deng K, Cao JL, et al. N -Acetylcysteine Alleviates Phenylephrine-Induced Cardiomyocyte Dysfunction via Engaging PI3K/AKT Signaling Pathway. American Journal of Hypertension. 2024. doi:10.1093/ajh/hpad100
BibTeX
@article{Chao2024,
author = {Chao, Sheng-Ping and Cheng, Wen-Lin and Yi, Wenjuan and Cai, Huan-Huan and Deng, Keqiong and Cao, Jian-Lei and Zeng, Ziyue and Wang, Hairong and Wu, Xiaoyan},
title = {N -Acetylcysteine Alleviates Phenylephrine-Induced Cardiomyocyte Dysfunction via Engaging PI3K/AKT Signaling Pathway},
journal = {American Journal of Hypertension},
year = {2024},
doi = {10.1093/ajh/hpad100}
}
EUVIMED